If You Would Like To Depress Your Immune System, Get This Year’s Flu Shot

Prevent Disease
by Dave Mihalovic

Other than a depressed immune system with a side serving of carcinogenic, immunotoxic, neurotoxic, and sterility agents, this year’s flu shot has nothing to offer you but the usual poisons based on previous formulations. Moreover, their effectiveness in preventing the flu is less than a placebo. Although the FDA gave a two year deadline to remove thimerosal from vaccines after they were banned in 1997, they continue to appear in vaccine formulations and ironically the FDA is now only supporting these drugs, not prohibiting them.

In 2009, eight out of ten H1N1 vaccines had thimerosal. For last year’s 2011/2012 flu vaccine season, three out of five FDA approved vaccines has thimerosal.

If you have any doubts on the neurotoxic potential of thimerosal, please review the following scientific publications which document the adverse effects of mercury, merthiolate and ethyl mercury.

This year, the 2012/2013 season offers three out of six flu vaccines which contain thimerosal and all are FDA approved of course.

Note that for every single vaccine, the carcinogenic or mutagenic potential has not been evaluated, or for impairment of fertility. This means that none of the carcinogenic excipients (inside every vaccine) are ever studied and their effects on the human body are unknown. This declaration also indicates that there is no responsible authority that can state to a parent, that their son or daughter will not become infertile as a consequence of receiving the influenza vaccine.

Another remarkable fact is that although all pregnant women are encouraged to receive the flu vaccine by health and medical authorities, the safety and effectiveness for pregnant women or nursing mothers has also not been established. Perhaps this is why studies show many spontaneous abortions and stillbirths after pregnant women are vaccinated.

////// 2012/2013 FDA APPROVED FLU VACCINES //////

1. AFLURIA 2012/2013
Manufactured by CSL Limited

Ingredients/Excipients:
Beta-Propiolactone: Carcinogen
Monobasic Potassium Phosphate: Immunotoxin
Neomycin: Immunotoxin
Polymyxin: Neurotoxin
Potassium Chloride: Neurotoxin
Sodium Deoxycholate: Immunotoxin

Safety and effectiveness of AFLURIA have not been established in
pregnant women or nursing mothers.
AFLURIA is not approved for use in children less than 5 years of age.
AFLURIA has not been evaluated for carcinogenic or mutagenic potential.

**************************************************

 2. FLUVARIX 2012/2013
Manufactured by GlaxoSmithKline
Ingredients/Excipients:

Formaldehyde : Carcinogen
Gentamicin Sulfate: Nephrotoxic
Hydrocortisone: Myelin Degenerator
Octoxynol 10 (TRITON X-100): Immunotoxin
Polysorbate 80 (Tween 80): Sterilie Agent
Sodium Deoxycholate: Immunotoxin
Safety and effectiveness of FLUARIX have not been established in pregnant women or nursing mothers.

FLUARIX has not been evaluated for carcinogenic or mutagenic potential, or for impairment of fertility.

***************************************************

3. FLULAVAL 2012/2013
Manufactured by ID Biomedical Corporation

Ingredients/Excipients:
Formaldehyde: Carcinogen
Sodium Deoxycholate: Immunotoxin
Thimerosal: Neurotoxin

Safety and effectiveness of FLULAVAL have not been established in pregnant women, nursing mothers, or children.

FLULAVAL has not been evaluated for carcinogenic or mutagenic potential, or for impairment of fertility.

***************************************************

4. FLUMIST 2012/2013
Manufactured by MedImmune Vaccines Inc.

Ingredients/Excipients:
Gelatin: Allergen
Gentamicin: Nephrotoxic
Monobasic Potassium Phosphate: Immunotoxin
Monosodium Glutamate: Neurotoxin

Safety and effectiveness of FLUMIST have not been established in pregnant women, nursing mothers, geriatric adults, or children less than 2 years of age.

FLUMIST has not been evaluated for its carcinogenic or mutagenic potential or its potential to impair fertility

***************************************************

5. FLUVIRIN 2012/2013
Manufactured by Novartis Vaccines

Ingredients/Excipients:
Beta-Propiolactone: Carcinogen
Neomycin: Immunotoxin
Polymyxin: Neurotoxin
Thimerosal: Neurotoxin

FLUVIRIN is not indicated for children less than 4 years of age because there is evidence of diminished immune response in this age group

FLUVIRIN has not been evaluated for carcinogenic or mutagenic potential, or for impairment of fertility.

***************************************************

6. FLUZONE 2012/2013
Manufactured by Sanofi Pasteur

Ingredients/Excipients:
Gelatin: Allergen
Formaldehyde: Carcinogen
Octoxynol 10 (TRITON X-100): Immunotoxin
Thimerosal: Neurotoxin

Safety and effectiveness of Fluzone has not been established in pregnant women.

Fluzone has not been evaluated for carcinogenic or mutagenic potential, or for impairment of fertility.

***************************************************

I recently wrote on how every single vaccine is now being exposed for the lack of demonstrated evidence to actually prevent a single case of disease over a placebo.

Flu vaccines are never tested in humans before they are produced to scale. It doesn’t matter what type of flu vaccine it is…it is categorically impossible to test a flu vaccine before it is mass produced on the scale that flu vaccines are manufactured today. It takes several years for most vaccines to move from preclinical development to the marketplace.

Before a vaccine enters human testing, the developer conducts laboratory (in vitro) and laboratory animal (in vivo) testing to determine whether the product will be safe enough for researchers to proceed to clinical trials. If a flu vaccine were to follow the standard development procedures, by the time it would actually enter the marketplace it would be useless, since the strain it was testing against during clinical development has now changed. This is the nature of vaccine development versus flu viruses and something the vaccine industrial complex will never admit to.

A recent report which is again being highlighted by the alternative media is a remarkable study published in the Cochrane Library which found no evidence of benefit for influenza vaccinations and also noted that the vast majority of trials were inadequate.

The authors found that vaccines administered parenterally, that is, outside the digestive tract, usually meaning by injection, reduced influenza-like symptoms by 4%. They found no evidence that vaccination prevents viral transmission putting the whole herd immunity myth once again into question.

The maximum success rate of the flu vaccine is 6.25% which is a pretty big under-achievement, considering that the average reaction to placebo injections of distilled water is 30%.

The Cochrane Collaboration, an international not-for-profit organization providing up-to-date information about the effects of health care, has compiled data from 40 flu seasons worldwide.

The institute has concluded from the studies that there is no clear evidence to suggest that the flu jab offers any more protection than cheaper, hygiene-based methods such as hand-washing.

“Our analysis is compiled using millions of data from 40 seasons worldwide. What we have seen is that the influenza vaccine can at best have a very small effect,” said Thomas Jefferson, one of the authors of the report, to the newspaper.

More independent scientific studies are also coming forth showing evidence of massive fetal toxicity associated with flu vaccines. Recent research I reported on is now published in the journal Human & Experimental Toxicology showing a 4,250% increase in fetal deaths according to Vaccine Adverse Event Reporting System (VAERS) data when comparing three consecutive influenza seasons.

Related: Paul Offit Threatens All Vaccine Exemptions – An MD Responds 
The Goal of Every H1N1 Swine Flu Vaccine:  Immunotoxicity, Neurotoxicity and Sterility
Hysteria Part Of Flu Epidemic

Switzerland, Italy Ban Novartis Flu Vaccines

WSJ

By MARTA FALCONI

Switzerland’s health regulator imposed an immediate ban on Novartis AG’s NOVN.VX +0.09% flu vaccines Thursday after possibly contaminated flu shots were found in batches in Italy, in a further embarrassment for the Swiss drug maker, which has struggled with a raft of manufacturing problems recently.

Medical watchdog Swissmedic halted deliveries of up to 160,000 doses to doctors and pharmacies as a precaution following a similar move by Italian authorities. The ban comes at an awkward time shortly before the flu season starts. There is already a shortage of flu vaccines in Switzerland and Italy this year after Netherlands-based vaccine maker Crucell, a unit of American drug maker Johnson & Johnson, JNJ -0.34% had suspended a delivery of seasonal flu vaccine across Europe last week.

In Austria, health authorities said they’ve issued a recommendation to doctors and pharmacies to switch to other flu vaccines than the Novartis products.

Novartis said the Italian health ministry had acted after the company itself reported the presence of small particles in the vaccines.

Problems with its flu vaccines represent a new blow for the Swiss drug maker, which has struggled with a series of manufacturing problems recently. The Basel-based company is still trying to resume production at its troubled facility in Lincoln, Nebraska, which was shut down in December because of manufacturing flaws, and recently had to recall a birth-control pill because of a packaging error.

Novartis Chief Executive Joe Jimenez in a call with journalists sought to reassure that its flu shots are safe, adding that the company is cooperating with health authorities.

“We are confident that the safety of the vaccines is assured. The lot in question had a deviation, it has been identified and put on hold and has not been released to the market,” he said. “The manufacturing of vaccines is a complex procedure. Italian authorities are free to continue investigating,” but there is evidence that such deviations wouldn’t affect safety or efficacy, Mr. Jimenez said.

Novartis produces a big chunk of its flu vaccines in Italy, from where they are shipped to Europe and parts of Asia. Mr. Jimenez said he didn’t expect more countries to ban the vaccines, even though he couldn’t rule it out. Vaccines for the U.S. market are produced in Liverpool, England, and aren’t affected, Novartis said.

Italian and Swiss authorities have advised doctors and nurses not to use the flu shots after small white particles were spotted in the syringes. Swissmedic said that it is possible that some of the ordinary components of the vaccines had clumped together. Novartis said these particles are proteins, which are normal and necessary components of flu vaccines.

“It is now Novartis’s task to find out what is wrong and which batches are concerned,” Swissmedic spokesman Daniel Lüthi said, a process that may be complicated because of the high number of doses potentially affected. “We have to wait until they can give us new results and more evidence.” If the products are found to be contaminated they have to be destroyed by the manufacturer, Mr. Lüthi said.

Italy had ordered 3 million doses from Novartis, but it wasn’t immediately clear how many of those had already been delivered to date.

The ban could create further embarrassment to the company, even though contamination issues are an industrywide problem, analysts say.

“Injectable drugs are very difficult to produce, and the risk of contamination is higher in liquids than it is in solids, such as tablets. It can affect not only vaccines but also cancer therapies, even though flu vaccines are much closer to consumers than chemotherapy drugs, so that’s an additional reputation problem for Novartis,” said Birgit Kulhoff, who manages a health care portfolio for private bank Rahn & Bodmer in Zurich.

The U.S. Food and Drug Administration last year sent a warning letter to Novartis’s generics unit, Sandoz, saying the unit had failed to correct repeated manufacturing violations in the U.S. Over the past few years, other pharmaceutical companies, including Johnson & Johnson and Sanofi have been warned over manufacturing issues at their plants.

Also in Italy, authorities last week started an investigation into alleged widespread corruption at Sandoz, whose representatives in the country are suspected of allegedly offering perks including trips and cash to 67 doctors, including pediatricians, to increase the number of their drugs prescriptions.

Mr. Jimenez declined to comment on the Italian investigation regarding Sandoz because it is still under way. “If there’s any issue within Novartis regarding compliance and marketing practices we would act immediately,” he said, without elaborating.

Related: FDA Updates Warnings: The Rotarix Oral Vaccine

300,000 Flu Vaccines Recalled Over Serious Adverse Reactions

Natural Society, Nov. 10, 2011

Baxter Healthcare Corp. has announced it is recalling around 300,000 doses of its Preflucel flu vaccine due to an ‘excessive’ amount of adverse reactions. Recalled from thousands of pharmacies and surgeries across Europe, the 300,000 units are to be immediately withdrawn. With seasonal flu vaccines already linked to nerve disease Guillain-Barre Syndrome and narcolepsy and still being given out liberally to citizens worldwide, the adverse reactions must be quite serious in order to prompt a recall.

Even more concerning is the fact that vaccine makers actually have been given legal immunity thanks to a law signed by Secretary of Health and Human Services Kathleen Sebelius.

Of course Baxter representatives are urging the public to stay calm, while also downplaying the risks associated with the shot. In the past NaturalSociety has revealed how Merck uses similar tactics to downplay the true side effects of the Gardasil vaccine, listing only minor side effects and ignoring the death link completely.

“The vaccine is being recalled because these side effects have been reported more frequently with this specific batch,” said a Baxter spokesmen. This spokesman also attempted to reassure the public that those who have already been vaccinated with Preflucel “should not be concerned (for their safety).”

Only time will tell what serious reactions are associated with this batch of Preflucel. In response to why the vaccine was recalled, Baxter states that “most of the side-effects are those usually associated with flu vaccines – they have started shortly after the vaccination and have been mild and short-lived.”

The problem with this statement is the fact that the seasonal flu shot has been repeatedly tied with serious adverse reactions. Therefore, it is not very reassuring that ‘most of the side-effects’ occur in the regular seasonal flu shot as well. Furthermore, it seems unlikely that Baxter would not recall flu vaccines, or at least investigate them further, after it was found that they are virtually ineffective and linked to nerve disease if they truly cared about your health. Therefore, it seems reasonable that despite the reassuring language of the Baxter spokesmen, this batch of Preflucel must be linked to something quite nasty.

Full story

Related: Immune System Protects Against Flu, Not Vaccines